Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.
about
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog.Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.A review of systemic anticancer therapy in disease palliation.Metastatic spread and common symptoms. Part six: Advanced cancer of the pancreas, prostate, stomach, and uterus.
P2860
Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Advances in the treatment of p ...... Antonio Drug Development Team.
@ast
Advances in the treatment of p ...... Antonio Drug Development Team.
@en
type
label
Advances in the treatment of p ...... Antonio Drug Development Team.
@ast
Advances in the treatment of p ...... Antonio Drug Development Team.
@en
prefLabel
Advances in the treatment of p ...... Antonio Drug Development Team.
@ast
Advances in the treatment of p ...... Antonio Drug Development Team.
@en
P2093
P2860
P921
P356
P1476
Advances in the treatment of p ...... Antonio Drug Development Team.
@en
P2093
A L Goodwin
D D Von Hoff
P2860
P2888
P356
10.1038/BJC.1998.748
P407
P478
78 Suppl 3
P577
1998-01-01T00:00:00Z